Finance

Lists
RIG2:FRA
Gedeon Richter Ord Shs
€35.18
+0.51%
(+0.18) 1D
Sep 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for RIG2...
Open
€34.58
High
€35.18
Low
€34.58
Avg. vol.
356.00
Volume
352.00
52-wk high
€37.02
52-wk low
€24.60
No. of employees
11K
Open
€34.58
High
€35.18
Low
€34.58
Avg. vol.
356.00
Volume
352.00
52-wk high
€37.02
52-wk low
€24.60
No. of employees
11K
Profile
Gedeon Richter Plc. is a Hungarian multinational pharmaceutical and biotechnology company headquartered in Budapest. Founded in 1901 by pharmacist Gedeon Richter, it is listed on the Budapest Stock Exchange under the ticker symbol RICHTER and is a constituent of the BUX Index. Wikipedia
About Gedeon Richter Ord Shs
CEOGábor Orbán
Employees11.2K
Founded1901
Headquarters-
SectorPharmaceutical industry
Websitegedeonrichter.com
Previous reportsAll values in HUF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HUF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
214.69B
248.76B
220.20B
241.39B
Cost of goods sold
62.75B
86.50B
72.45B
72.35B
Cost of revenue
62.75B
86.50B
72.45B
72.35B
Research and development expenses
19.47B
22.86B
22.85B
22.90B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.30B
52.27B
55.32B
57.76B
Operating expense
88.86B
67.38B
80.38B
89.48B
Total operating expenses
151.62B
153.88B
152.84B
161.83B
Operating income
63.07B
94.88B
67.37B
79.56B
Other non operating income
2.30B
-2.50B
-
3.43B
EBT including unusual items
52.10B
87.59B
78.78B
45.93B
EBT excluding unusual items
51.04B
93.91B
78.78B
49.30B
Income tax expense
8.66B
18.91B
13.30B
7.78B
Effective tax rate
16.63%
21.59%
16.89%
16.93%
Other operating expenses
17.10B
-11.00B
2.21B
8.83B
Net income
43.35B
69.01B
65.28B
38.26B
Net profit margin
20.19%
27.74%
29.65%
15.85%
Earnings per share
-
-
-
-
Interest and investment income
6.00B
11.63B
26.16B
9.56B
Interest expense
-3.60B
-10.52B
-15.63B
-16.14B
Net interest expenses
2.40B
1.10B
10.52B
-6.57B
Depreciation and amortization charges
-
-
-
-
EBITDA
81.50B
104.28B
83.47B
93.79B
Gain or loss from assets sale
-
1.41B
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps